Regenerative Medicine Q3
- 期刊收录:
- SCIE
- Scopus
- 期刊ISSN:
1746-0751
- 期刊简拼:
REGEN MED
- 年发文章数:
51
- E-ISSN:
1746-076X
- Gold OA文章占比
25.41%
- 研究文章占比:
70.59%
- 是否OA:
No
- Jcr分区:
Q3
- 中科院分区:
4区
- 出版商:
Future Medicine Ltd.
- 涉及研究方向:
医学-工程:生物医学
- 出版国家:
ENGLAND
- 出版语言:
English
- 出版周期:
Bimonthly
- 出版年份:
2006
- 2023-2024最新影响因子:2.4
- 自引率:8.30%
- 五年影响因子:2.8
- JCI期刊引文指标:0.44
- h-index:53
- CiteScore:4.20
期刊简介
Regenerative medicine replaces or regenerates human cells, tissue or organs, to restore or establish normal function*. Since 2006, Regenerative Medicine has been at the forefront of publishing the very best papers and reviews covering the entire regenerative medicine sector. The journal focusses on the entire spectrum of approaches to regenerative medicine, including small molecule drugs, biologics, biomaterials and tissue engineering, and cell and gene therapies – it’s all about regeneration and not a specific platform technology. The journal’s scope encompasses all aspects of the sector ranging from discovery research, through to clinical development, through to commercialization. Regenerative Medicine uniquely supports this important area of biomedical science and healthcare by providing a peer-reviewed journal totally committed to publishing the very best regenerative medicine research, clinical translation and commercialization.
Regenerative Medicine provides a specialist forum to address the important challenges and advances in regenerative medicine, delivering this essential information in concise, clear and attractive article formats – vital to a rapidly growing, multidisciplinary and increasingly time-constrained community.
Despite substantial developments in our knowledge and understanding of regeneration, the field is still in its infancy. However, progress is accelerating. The next few decades will see the discovery and development of transformative therapies for patients, and in some cases, even cures. Regenerative Medicine will continue to provide a critical overview of these advances as they progress, undergo clinical trials, and eventually become mainstream medicine.
《Regenerative Medicine》期刊已被查看: 次
期刊简写:REGEN MED
此期刊被最新的JCR期刊SCIE收录
期刊信息
- PubMed Central (PMC)链接
- http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1746-0751%5BISSN%5D
- 通讯地址
- FUTURE MEDICINE LTD, UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, ENGLAND, N3 1QB
- 中国科学院《国际期刊预警名单(试行)》名单
-
2024年02月发布的2024版:不在预警名单中
2023年01月发布的2023版:不在预警名单中
2021年12月发布的2021版:不在预警名单中
2020年12月发布的2020版:不在预警名单中
此期刊被最新的JCR期刊SCIE收录
- 审稿速度
- 收录数据库
- 是否oa
- 研究方向
- 较慢,6-12周
- SCIE,Scopus
- No
- 医学-工程:生物医学
分区信息
- 大类学科
- 分区
- 小类学科
- Top期刊
- 综述期刊
- 医学
- 4区
- CELL & TISSUE ENGINEERING
细胞与组织工程
ENGINEERING
BIOMEDICAL
工程:生物医学 - 否
- 否
- 版本
- 按学科
- 分区
- 影响因子
- WOS期刊SCI分(2023-2024年最新版)
- CELL & TISSUE ENGINEERING
ENGINEERING
BIOMEDICAL - Q3
- 2.4
IF值(影响因子)趋势图
年发文量趋势图
自引率趋势图
中科院分区
常见问题
-
sci四区价格多少算合理?
一篇sci4区是sci里最便宜的了 价格一般在3-4左右,如果有人告诉你几k就能发或者五位数出头,个人建议谨慎一点,不能因为贪小便宜吃大亏如果四区就能满足学
《Regenerative Medicine》同类:医学期刊
-
MaternalFetal Medicine
JCR:0区--分类:医学
影响因子0
收录Scopus,DOAJ
-
Precision Clinical Medicine
JCR:1区--分类:医学
影响因子5.1
收录ESCI,Scopus,DOAJ
-
Arthroplasty
JCR:2区--分类:医学
影响因子2.3
收录ESCI,Scopus,DOAJ
-
JHEP Reports
JCR:1区--分类:医学
影响因子9.5
收录SCIE,Scopus,DOAJ
-
World Journal of Pediatric Surgery
JCR:4区--分类:医学
影响因子0.8
收录ESCI,Scopus,DOAJ
-
Human Reproduction Open
JCR:1区--分类:医学
影响因子8.3
收录SCIE,Scopus,DOAJ
-
Animal Models and Experimental Medicine
JCR:2区--分类:医学
影响因子3.8
收录ESCI,Scopus,DOAJ
-
Brazilian Journal of Anesthesiology
JCR:2区--分类:医学
影响因子1.7
收录SCIE,Scopus,DOAJ